Search - tctmd.com

Displaying 1 - 20 of 58

Sort: Relevancy | Date

New-Generation Watchman FLX Maintains Good Results Through 2 Years

News Conference News TVT 2021

New-Generation Watchman FLX Maintains Good Results Through 2 Years

July 28, 2021

Optimizing Medical Therapy Before Clip Repair for MR? ‘This is Hard’

News Conference News TVT 2021

Optimizing Medical Therapy Before Clip Repair for MR? ‘This Is Hard’

July 27, 2021

3M TAVR: Minimalist TAVI Pathway Saves Money

News Conference News TVT 2021

3M TAVR: Minimalist TAVI Pathway Saves Money

July 26, 2021

Post-TAVI Pacemaker Rates Down in the US, but ‘Still Quite High’

News Conference News TVT 2021

Post-TAVI Pacemaker Rates Down in the US, but ‘Still Quite High’

July 23, 2021

Percutaneous Left Atrial Appendage Closure Versus Oral Anticoagulation for Non-Valvular Atrial Fibrillation: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Presentation TVT 2021

Percutaneous Left Atrial Appendage Closure Versus Oral Anticoagulation for Non-Valvular Atrial Fibrillation: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Presenter: Yousif Ahmad

July 22, 2021

Right Ventricular-Pulmonary Arterial Coupling and Afterload Reserve in Patients Undergoing Transcatheter Tricuspid Valve Therapy: Insights From the International TriValve Registry

Presentation TVT 2021

Right Ventricular-Pulmonary Arterial Coupling and Afterload Reserve in Patients Undergoing Transcatheter Tricuspid Valve Therapy: Insights From the International TriValve Registry

Presenter: Michael Brener

July 22, 2021

Six-month Outcomes for Transcatheter Repair From the Cardioband Tricuspid System Early Feasibility Study

Presentation TVT 2021

Six-month Outcomes for Transcatheter Repair From the Cardioband Tricuspid System Early Feasibility Study

Presenter: Charles Davidson

July 22, 2021

Actigraphy Demonstrates Long-term Improvement of Functional Capacity in Chronic Heart Failure After Transcatheter Tricuspid Valve Repair of Severe Tricuspid Regurgitation

Presentation TVT 2021

Actigraphy Demonstrates Long-term Improvement of Functional Capacity in Chronic Heart Failure After Transcatheter Tricuspid Valve Repair of Severe Tricuspid Regurgitation

Presenter: Jörg Hausleiter

July 22, 2021

Anatomic Predictors and Impact on Outcomes of Mitral Valve gradient, Results From the MitraClip™ EXPAND Study

Presentation TVT 2021

Anatomic Predictors and Impact on Outcomes of Mitral Valve gradient, Results From the MitraClip™ EXPAND Study

Presenter: Gagan Singh

July 22, 2021

Implications of COVID-19 Related Reductions of HF Hospitalizations on Clinical Trials of HF Devices

Presentation TVT 2021

Implications of COVID-19 Related Reductions of HF Hospitalizations on Clinical Trials of HF Devices

Presenter: JoAnn Lindenfeld

July 22, 2021

Impact of Transcatheter Valve Type on Outcomes of Surgical Explanation After Failed TAVR: Mid-Term Results From the EXPLANT-TAVR International Registry

Presentation TVT 2021

Impact of Transcatheter Valve Type on Outcomes of Surgical Explanation After Failed TAVR: Mid-Term Results From the EXPLANT-TAVR International Registry

Presenter: Syed Zaid

July 22, 2021

How Changes in GDMT for HF Are Impacting Clinical Trials of HF Devices

Presentation TVT 2021

How Changes in GDMT for HF Are Impacting Clinical Trials of HF Devices

Presenter: Susan M. Joseph

July 22, 2021

1-Year Clinical Outcomes of ASD Closure following Transseptal Mitral Valve-in-Valve Procedures Using SAPIEN 3 Valve Prosthesis in a Propensity-Matched Analysis

Presentation TVT 2021

1-Year Clinical Outcomes of ASD Closure following Transseptal Mitral Valve-in-Valve Procedures Using SAPIEN 3 Valve Prosthesis in a Propensity-Matched Analysis

Presenter: Andrew Morse

July 22, 2021

Propensity Score-Weighted Comparison of 30-day Outcomes for Transcatheter Mitral Valve Replacement Versus Repeat Surgical Mitral Valve Replacement – A Contemporary Assessment of Real-World Outcomes

Presentation TVT 2021

Propensity Score-Weighted Comparison of 30-day Outcomes for Transcatheter Mitral Valve Replacement Versus Repeat Surgical Mitral Valve Replacement – A Contemporary Assessment of Real-World Outcomes

Presenter: Tsuyoshi Kaneko

July 22, 2021

The Role of the RV and PA in Determining Clinicial Outcomes of Procedures on the LV (MitraClip and TAVR)

Presentation TVT 2021

The Role of the RV and PA in Determining Clinicial Outcomes of Procedures on the LV (MitraClip and TAVR)

Presenter: Philipp Lurz

July 22, 2021

Economics of Minimalist TAVR: Results From the 3M-TAVR Economic Study

Presentation TVT 2021

Economics of Minimalist TAVR: Results From the 3M-TAVR Economic Study

Presenter: Neel Butala

July 22, 2021

Pascal Device Works Well for Tricuspid Regurgitation in Commercial Market

News Conference News TVT 2021

Pascal Device Works Well for Tricuspid Regurgitation in Commercial Market

July 22, 2021

Trends in Practice Patterns and Outcomes of Transcatheter Aortic Valve Replacement in The US and Japan: A Joint Data Harmonization Initiative of STS/ACC TVT and J-TVT

Presentation TVT 2021

Trends in Practice Patterns and Outcomes of Transcatheter Aortic Valve Replacement in The US and Japan: A Joint Data Harmonization Initiative of STS/ACC TVT and J-TVT

Presenter: Tsuyoshi Kaneko

July 22, 2021

National Trends in Permanent Pacemaker Implantation After Transcatheter Aortic Valve Replacement: An Analysis From the STS/ACC TVT Registry

Presentation TVT 2021

National Trends in Permanent Pacemaker Implantation After Transcatheter Aortic Valve Replacement: An Analysis From the STS/ACC TVT Registry

Presenter: Katherine Chau

July 22, 2021

Valve-in-Valve TAVR vs Reoperative SAVR in Patients With Failed Aortic Bioprosthesis: Insight from Nationwide Readmission Database

Presentation TVT 2021

Valve-in-Valve TAVR vs Reoperative SAVR in Patients With Failed Aortic Bioprosthesis: Insight from Nationwide Readmission Database

Presenter: Ankur Kalra

July 22, 2021

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.